Sung H, Ferlay J, Siegel RL et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249.

Article  PubMed  Google Scholar 

Kitagawa Y, Ishihara R, Ishikawa H et al. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1. Esophagus. 2023;20:343–372.

Article  PubMed  PubMed Central  Google Scholar 

Yagi K, Toriumi T, Aikou S, Yamashita H, Seto Y. Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Ann Gastroenterol Surg. 2021;5:436–445.

Article  PubMed  PubMed Central  Google Scholar 

Chen Y, Lu Y, Wang Y et al. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone: Salvage therapy for recurrent ESCC. Dis Esophagus. 2014;27:134–140.

Article  CAS  PubMed  Google Scholar 

Tachimori Y, Kanamori N, Uemura N, Hokamura N, Igaki H, Kato H. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2009;137:49–54.

Article  PubMed  Google Scholar 

Takeuchi H, Saikawa Y, Oyama T et al. Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy. World J Surg. 2010;34:277–284.

Article  PubMed  Google Scholar 

Hayami M, Watanabe M, Ishizuka N et al. Prognostic impact of postoperative pulmonary complications following salvage esophagectomy after definitive chemoradiotherapy. J Surg Oncol. 2018;117:1251–1259.

Article  PubMed  Google Scholar 

Cohen C, Tessier W, Gronnier C et al. Salvage surgery for esophageal cancer: How to improve outcomes? Ann Surg Oncol. 2018;25:1277–1286.

Article  PubMed  Google Scholar 

Kiyozumi Y, Yoshida N, Ishimoto T et al. Prognostic factors of salvage esophagectomy for residual or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy. World J Surg. 2018;42:2887–2893.

Article  PubMed  Google Scholar 

Mitchell KG, Nelson DB, Corsini EM, et al. Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience. Dis Esophagus. 2020;33.

Sugimura K, Miyata H, Shinno N et al. Prognostic impact of postoperative complications following salvage esophagectomy for esophageal cancer after definitive chemoradiotherapy. Oncology. 2020;98:280–288.

Article  PubMed  Google Scholar 

Noordman BJ, de Bekker-Grob EW, Coene PPLO et al. Patients’ preferences for treatment after neoadjuvant chemoradiotherapy for oesophageal cancer: Patients’ preferences for treatment after chemoradiation for oesophageal cancer. Br J Surg. 2018;105:1630–1638.

Article  CAS  PubMed  Google Scholar 

Hatogai K, Yano T, Kojima T et al. Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Gastrointest Endosc. 2016;83:1130-1139.e3.

Article  PubMed  Google Scholar 

Yano T, Muto M, Hattori S et al. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy. 2008;40:717–721.

Article  CAS  PubMed  Google Scholar 

Kagawa T, Ishikawa S, Inaba T et al. Clinicopathological examination of ESD as salvage therapy for esophageal cancer after definitive chemo-radiation therapy. Endosc Int Open. 2018;6:E450–E461.

Article  PubMed  PubMed Central  Google Scholar 

Nagai Y, Yoshida N, Baba H. Salvage treatment for superficial local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Dig Endosc. 2020;32:146.

Article  PubMed  Google Scholar 

Kimura H, Yoshida M, Yabuuchi Y et al. Long-term outcomes of salvage endoscopic submucosal dissection for local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Jpn J Clin Oncol. 2021;51:1036–1043.

Article  PubMed  Google Scholar 

Nakajo K, Yoda Y, Hori K et al. Technical feasibility of endoscopic submucosal dissection for local failure after chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma. Gastrointest Endosc. 2018;88:637–646.

Article  PubMed  Google Scholar 

Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–655.

Article  CAS  PubMed  Google Scholar 

Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–458.

Article  CAS  PubMed  Google Scholar 

Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev. 2006;CD002092.

Kato H, Sato A, Fukuda H et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol. 2009;39:638–643.

Article  PubMed  Google Scholar 

Kato K, Muro K, Minashi K et al. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys. 2011;81:684–690.

Article  CAS  PubMed  Google Scholar 

Sudo K, Kato K, Kuwabara H et al. Patterns of relapse after definitive chemoradiotherapy in stage II/III (non-T4) esophageal squamous cell carcinoma. Oncology. 2018;94:47–54.

Article  CAS  PubMed  Google Scholar 

Ohtsu A, Boku N, Muro K et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999;17:2915–2921.

Article  CAS  PubMed  Google Scholar 

Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Jpn J Clin Oncol. 2004;34:615–619.

Article  PubMed  Google Scholar 

Versteijne E, van Laarhoven HWM, van Hooft JE et al. Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern: DCRT oesophageal cancer: recurrence pattern. Dis Esophagus. 2015;28:453–459.

Article  CAS  PubMed  Google Scholar 

Takeuchi H, Ito Y, Machida R et al. A single-arm confirmatory study of definitive chemoradiation therapy including salvage treatment for clinical stage II/III esophageal squamous cell carcinoma (JCOG0909 study). Int J Radiat Oncol Biol Phys. 2022;114:454–462.

Article  PubMed  Google Scholar 

Takeuchi M, Kobayashi M, Hashimoto S et al. Salvage endoscopic submucosal dissection in patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Scand J Gastroenterol. 2013;48:1095–1101.

Article  CAS  PubMed  Google Scholar 

Koizumi S, Jin M, Matsuhashi T et al. Salvage endoscopic submucosal dissection for the esophagus-localized recurrence of esophageal squamous cell cancer after definitive chemoradiotherapy. Gastrointest Endosc. 2014;79:348–353.

Article  PubMed  Google Scholar 

Makazu M, Kato K, Takisawa H et al. Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer: Salvage EMR for esophageal cancer. Dis Esophagus. 2014;27:42–49.

Article  CAS  PubMed  Google Scholar 

Hatogai K, Yano T, Kojima T et al. Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer. Radiat Oncol. 2016;11:31.

Article  PubMed  PubMed Central  Google Scholar 

Kondo S, Tajika M, Tanaka T et al. Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone. Endosc Int Open. 2016;4:E841–E848.

Article  PubMed  PubMed Central  Google Scholar 

Ego M, Abe S, Nakatani Y et al. Correction to: Long-term outcomes of patients with recurrent squamous cell carcinoma of the esophagus undergoing salvage endoscopic resection after definitive chemoradiotherapy. Surg Endosc. 2021;35:1777.

Article  PubMed